Medicare's new GLP-1 Bridge program offers weight-loss drugs for $50 a month, but the copay sidesteps Part D's cap and Extra ...

The GLP-1 Payment Demonstration is bringing affordable weight loss medication to Medicare Part D beneficiaries.

The drugs covered under the program include Wegovy tablets and injections, Zepbound KwikPens, and Foundayo tablets ...

For Medicare beneficiaries prescribed a glucagon-like petide-1 (GLP-1) receptor agonist, eligibility rules are far from ...

Millions of Americans on Medicare will have access to prescription weight loss medications for the first time starting July 1 under a new federal program that caps the monthly cost at $50. The program ...

Retirees covered by Medicare Part D are set to see new relief from high prescription drug costs in 2025. Annual out-of-pocket costs will be capped at $2,000 starting in January. New research from the ...

Are you eligible to get the weight loss drugs? Here is a look at the ...

For years, GLP-1 drugs like Wegovy and Zepbound have transformed the discussion around obesity — but left millions locked out by high price tags, including Medicare recipients. That changes this week.

You can sign up for a Medicare Part D drug plan when initially eligible for Original Medicare. There’s a 3-month period starting when your Medicare parts A and B become active. During this time, you ...

Medicare agents are fighting back against the recent decision by some health plans to discontinue paying commissions on Medicare Part D plans. More than 600 agents signed a petition on Change.org, ...